ConductScience.org, home

Paper · 30769860

Progressive Oncological Surgery Is Associated with Increased Curative Resection Rates and Improved Survival in Metastatic Colorectal Cancer.

Primavesi F and 11 others. Cancers (Basel), 2019. Cited by 10 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Progressive Oncological Surgery Is Associated with Increased Curative Resection Rates and Improved Survival in Metastatic Colorectal Cancer. Papers, record 30769860. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30769860

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Progressive Oncological Surgery Is Associated with Increased Curative Resection Rates and Improved Survival in Metastatic Colorectal Cancer.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2019
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
0.34
iCite
Revised in PubMed
2020-09-29
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Primavesi FFlorianhttps://orcid.org/0000-0003-2707-6307
2Stättner SStefanhttps://orcid.org/0000-0002-5226-7597
3Jäger TTarkanhttps://orcid.org/0000-0002-2390-0226
4Göbel GGeorg
5Presl JJaroslav
6Tomanová KKaterina
7Buchner SSelina
8Maglione MManuel
9Resch TThomas
10Hutter JJörg

1 to 10 of 12Source PubMed

See all 12 authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References55

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110,986,214Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study.Gut2000https://conductscience.org/library/papers/10986214PubMed
212,035,031Trends in long-term survival following liver resection for hepatic colorectal metastases.Ann Surg2002https://conductscience.org/library/papers/12035031PubMed
312,892,803Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis.J Am Coll Surg2003https://conductscience.org/library/papers/12892803PubMed
415,273,542Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.Ann Surg2004https://conductscience.org/library/papers/15273542PubMed
517,103,293Survival of patients with colorectal cancer in Austria by sex, age, and stage.Wien Med Wochenschr2006https://conductscience.org/library/papers/17103293PubMed
617,371,210Comparing survival outcomes for patients with colorectal cancer treated in public and private hospitals.Med J Aust2007https://conductscience.org/library/papers/17371210PubMed
717,596,575Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials.J Natl Cancer Inst2007https://conductscience.org/library/papers/17596575PubMed
817,981,429Bringing unresectable liver disease to resection with curative intent.Eur J Surg Oncol2007https://conductscience.org/library/papers/17981429PubMed
918,006,265Extending the frontiers of resectability in advanced colorectal cancer.Eur J Surg Oncol2007https://conductscience.org/library/papers/18006265PubMed
1018,064,739The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.Lancet2007https://conductscience.org/library/papers/18064739PubMed

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
37,526,431Isolated pulmonary metastases in pancreatic ductal adenocarcinoma: a review of current evidence.Cancer Biol Ther2023https://conductscience.org/library/papers/37526431PubMed
35,330,491The Role of Preoperative Platelet-to-Lymphocyte Ratio as a Predictor for Incisional Hernias after Hand-Assisted Laparoscopic Liver Surgery for Metastatic Colorectal Cancer.J Pers Med2022https://conductscience.org/library/papers/35330491PubMed
33,256,240The Role of BRAF in Metastatic Colorectal Carcinoma-Past, Present, and Future.Int J Mol Sci2020https://conductscience.org/library/papers/33256240PubMed
32,391,100MicroRNA-758 acts as a tumor inhibitor in colorectal cancer through targeting PAX6 and regulating PI3K/AKT pathway.Oncol Lett2020https://conductscience.org/library/papers/32391100PubMed
32,183,226Recellularized Colorectal Cancer Patient-derived Scaffolds as in vitro Pre-clinical 3D Model for Drug Screening.Cancers (Basel)2020https://conductscience.org/library/papers/32183226PubMed
32,065,510Systematic review on peri-operative lactate measurements to predict outcomes in patients undergoing liver resection.J Hepatobiliary Pancreat Sci2020https://conductscience.org/library/papers/32065510PubMed
32,053,872Colorectal Cancer Research: Basic, Preclinical, and Clinical Approaches.Cancers (Basel)2020https://conductscience.org/library/papers/32053872PubMed
31,150,437
Primary tumour location affects survival after resection of colorectal liver metastases: A two-institutional cohort study with international validation, systematic meta-analysis and a clinical risk score.
PLoS One2019https://conductscience.org/library/papers/31150437PubMed

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BRAF673PubTator's text mininghttps://conductscience.org/library/genes/673NCBI Gene
CEACAM31,084PubTator's text mininghttps://conductscience.org/library/genes/1084NCBI Gene
EGFR1,956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
KRAS3,845PubTator's text mininghttps://conductscience.org/library/genes/3845NCBI Gene
NRAS4,893PubTator's text mininghttps://conductscience.org/library/genes/4893NCBI Gene
VEGFA7,422PubTator's text mininghttps://conductscience.org/library/genes/7422NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30769860

GET https://conductscience.org/api/papers/v1/30769860/references?page=2